代谢综合征特征与早期亚临床动脉粥样硬化受试者的心脏胰岛素抵抗
研究纳入821名无症状个体,间隔4.8±0.6年行两次全身18F-FDG PET-MR,评估心肌18F-FDG摄取与代谢综合征特征及早期动脉粥样硬化的关联。无心肌摄取者代谢综合征、高血压、糖尿病患病率及HOMA-IR更高,且与早期动脉粥样硬化相关;随访时代谢综合征改善与心肌摄取恢复相关。
要点
- 19.0%受试者无心肌18F-FDG摄取,其代谢综合征患病率29.0% vs 13.9%(P<0.001)。
- 无心肌摄取者高血压29.0% vs 18.0%(P=0.002)、糖尿病11.0% vs 3.2%(P<0.001)。
- HOMA-IR升高与心肌摄取进行性降低相关(P<0.001),代谢综合征改善与心肌摄取增加相关(P<0.001)。
核心结论
- 看似健康的无心肌18F-FDG摄取个体HOMA-IR更高,代谢综合征特征、心血管危险因素及早期动脉粥样硬化患病率更高。
- 随访时代谢心血管特征改善与心肌18F-FDG摄取恢复相关。
研究设计与样本
- 来自早期亚临床动脉粥样硬化进展(PESA)研究的821名无症状个体,年龄50.6(46.9-53.6)岁,男性83.7%。
- 间隔4.8±0.6年行两次全身18F-FDG PET-MR,定性及定量评估心肌18F-FDG摄取。
- 无心肌摄取为0级,阳性摄取按靶本比三分位分为1-3级。
主要发现
- 156名(19.0%)无心肌18F-FDG摄取,与代谢综合征患病率29.0% vs 13.9%(P<0.001)显著相关。
- 无心肌摄取者高血压29.0% vs 18.0%(P=0.002)、糖尿病11.0% vs 3.2%(P<0.001)、HOMA-IR 1.64% vs 1.23%(P<0.001)均更高。
- 无心肌摄取与早期动脉粥样硬化(动脉18F-FDG摄取)患病率更高相关(P=0.004)。
- 随访时心肌18F-FDG摄取与危险因素的关联被重复,无心肌摄取组代谢综合征更常见。
- HOMA-IR升高与心肌摄取进行性降低相关(P<0.001);82%受试者心肌摄取有无的分类在基线与随访间未变;随访时代谢综合征消退与心肌摄取显著增加相关(P<0.001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Experimental evidence suggests that metabolic syndrome (MetS) is associated with changes in cardiac metabolism. Whether this association occurs in humans is unknown. RESEARCH DESIGN AND METHODS: 821 asymptomatic individuals from the Progression of Early Subclinical Atherosclerosis (PESA) study (50.6 [46.9-53.6] years, 83.7% male) underwent two whole-body 18F-fluorodeoxyglucose positron emission tomography-magnetic resonance (18F-FDG PET-MR) 4.8 ± 0.6 years apart. Presence of myocardial 18F-FDG uptake was evaluated qualitatively and quantitatively. No myocardial uptake was grade 0, while positive uptake was classified in grades 1-3 according to target-to-background ratio tertiles. RESULTS: One hundred fifty-six participants (19.0%) showed no myocardial 18F-FDG uptake, and this was significantly associated with higher prevalence of MetS (29.0% vs. 13.9%, P < 0.001), hypertension (29.0% vs. 18.0%, P = 0.002), and diabetes (11.0% vs. 3.2%, P < 0.001), and with higher insulin resistance index (HOMA-IR, 1.64% vs. 1.23%, P < 0.001). Absence of myocardial uptake was associated with higher prevalence of early atherosclerosis (i.e., arterial 18F-FDG uptake, P = 0.004). On follow-up, the associations between myocardial 18F-FDG uptake and risk factors were replicated, and MetS was more frequent in the group without myocardial uptake. The increase in HOMA-IR was associated with a progressive decrease in myocardial uptake (P < 0.001). In 82% of subjects, the categorization according to presence/absence of myocardial 18F-FDG uptake did not change between baseline and follow-up. MetS regression on follow-up was associated with a significant (P < 0.001) increase in myocardial uptake. CONCLUSIONS: Apparently healthy individuals without cardiac 18F-FDG uptake have higher HOMA-IR and higher prevalence of MetS traits, cardiovascular risk factors, and early atherosclerosis. An improvement in cardiometabolic profile is associated with the recovery of myocardial 18F-FDG uptake at follow-up.
引用
- Devesa A, Fuster V, Vazirani R, et al. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis. Diabetes Care. 2023. PMID: 37713581. doi:10.2337/dc23-0871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。